Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis

for the DIAZ.001.05 Study Group

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Lack of clinically relevant differences in safety and pharmacokinetics after second-dose administration of intranasal diazepam within 4 h for acute treatment of seizure clusters: A population analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences